Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. Hashimoto completed his medical school training at the Kyushu University Faculty of Medicine in 1995. He completed his general surgery residency in 1997 before enrolling in a graduate student program leading to his PhD in 2001. He joined the Hiroshima Red Cross Hospital before being accepted in the ASTS approved multiorgan transplant fellowship training program at the Cleveland Clinic in 2006. After completing his training in 2008, he remained at the Cleveland Clinic as the Living Donor Liver Transplant Clinical Scholar. He is now Associate Staff at the Cleveland Clinic. Dr. Hashimoto holds board certification by the Japan Board of Surgery and certification by the American Society of Transplant Surgeons. He is a member of the American Society of Transplant Surgeons, the American Society of Transplantation, the American Association for the Study of Liver Diseases, the Transplantation Society, the American Medical Association, the Japan Surgical Society, the Japanese Society for Transplantation and the Japanese Society of Gastroenterological Surgery. Dr Hashimoto has already published over 60 manuscripts in peer-reviewed journals such as: American Journal of Transplantation, Liver Transplantation, Annals of Surgery, Surgery, Gene Therapy, Liver International, Journal of Hepatology, Cancer, Transplantation, Transplant International, Journal of General Virology, Virology, and Journal of Virology.
Assistant Professor of Surgery, Cleveland Clinic Lerner College of Medicine
Liver transplantation, living donor liver transplantation, intestinal transplantation, multi-visceral transplantation, hepatobiliary surgery, organ donation, pediatric liver transplant, organ recovery and preservation, immunosuppression
Awards & Honors
Vanguard Award for Outstanding Young Investigator, International Liver Transplantation Society - 2010
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 12/8/2016, Dr. Hashimoto has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.